|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 1/22 | |
| C12N 9/64 |
| (11) | Patento numeris | 2861614 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13732317.6 |
| Europos patento paraiškos padavimo data | 2013-06-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-11-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/045496 |
| Data | 2013-06-12 |
| (87) | Numeris | WO 2013/188587 |
| Data | 2013-12-19 |
| (30) | Numeris | Data | Šalis |
| 201261659821 P | 2012-06-14 | US |
| (72) |
LU, Genmin, US
SINHA, Uma, US
|
| (73) |
Portola Pharmaceuticals, Inc.,
270 East Grand Avenue Suite 22, South San Francisco, California 94080,
US
|
| (54) | METHOD FOR PURIFICATION OF RECOMBINANT FACTOR Xa DERIVATIVES |
| METHOD FOR PURIFICATION OF RECOMBINANT FACTOR Xa DERIVATIVES |